Finance

Beta
Lists
INDP:NASDAQ
Indaptus Therapeutics Inc
$3.53
-4.34%
(-0.16) 1D
Jun 16, 12:57:56 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INDP...
Open
$3.79
High
$3.79
Low
$3.41
Mkt. cap
399.75M
Avg. vol.
1.97M
Volume
175.69K
52-wk high
$19.91
52-wk low
$0.92
EPS
-$16.83
Beta
1.25
Shares outstanding
113.24M
No. of employees
5
Open
$3.79
High
$3.79
Low
$3.41
Mkt. cap
399.75M
Avg. vol.
1.97M
Volume
175.69K
52-wk high
$19.91
52-wk low
$0.92
EPS
-$16.83
Beta
1.25
Shares outstanding
113.24M
No. of employees
5
News stories
From sources across the web
About Indaptus Therapeutics Inc
CEOJeffrey A. Meckler
Employees5
Founded2021
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.17M
1.52M
2.85M
491.13K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.29M
1.13M
5.31M
1.67M
Operating expense
4.46M
2.65M
8.16M
2.16M
Total operating expenses
4.46M
2.65M
8.16M
2.16M
Operating income
-4.46M
-2.65M
-8.16M
-2.16M
Other non operating income
-772.16K
-326.63K
43.25K
-381.48K
EBT including unusual items
-5.23M
-2.98M
-8.11M
-2.54M
EBT excluding unusual items
-5.23M
-2.98M
-8.11M
-2.54M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.23M
-2.98M
-8.11M
-2.54M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.46M
-2.65M
-8.16M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more